263 related articles for article (PubMed ID: 32145376)
1. Longitudinal degeneration of the basal forebrain predicts subsequent dementia in Parkinson's disease.
Pereira JB; Hall S; Jalakas M; Grothe MJ; Strandberg O; Stomrud E; Westman E; van Westen D; Hansson O
Neurobiol Dis; 2020 Jun; 139():104831. PubMed ID: 32145376
[TBL] [Abstract][Full Text] [Related]
2. In vivo cholinergic basal forebrain atrophy predicts cognitive decline in de novo Parkinson's disease.
Ray NJ; Bradburn S; Murgatroyd C; Toseeb U; Mir P; Kountouriotis GK; Teipel SJ; Grothe MJ
Brain; 2018 Jan; 141(1):165-176. PubMed ID: 29228203
[TBL] [Abstract][Full Text] [Related]
3. Quantitative EEG and cholinergic basal forebrain atrophy in Parkinson's disease and mild cognitive impairment.
Rea RC; Berlot R; Martin SL; Craig CE; Holmes PS; Wright DJ; Bon J; Pirtošek Z; Ray NJ
Neurobiol Aging; 2021 Oct; 106():37-44. PubMed ID: 34233212
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal brain atrophy distribution in advanced Parkinson's disease: What makes the difference in "cognitive status" converters?
Gorges M; Kunz MS; Müller HP; Liepelt-Scarfone I; Storch A; Dodel R; Hilker-Roggendorf R; ; Berg D; Kalbe E; Braak H; Del Tredici K; Baudrexel S; Huppertz HJ; Kassubek J
Hum Brain Mapp; 2020 Apr; 41(6):1416-1434. PubMed ID: 31789477
[TBL] [Abstract][Full Text] [Related]
5. In vivo cholinergic basal forebrain degeneration and cognition in Parkinson's disease: Imaging results from the COPPADIS study.
Grothe MJ; Labrador-Espinosa MA; Jesús S; Macías-García D; Adarmes-Gómez A; Carrillo F; Camacho EI; Franco-Rosado P; Lora FR; Martín-Rodríguez JF; Barberá MA; Pastor P; Arroyo SE; Vila BS; Foraster AC; Martínez JR; Padilla FC; Morlans MP; Aramburu IG; Ceberio JI; Vara JH; de Fábregues-Boixar O; de Deus Fonticoba T; Pascual-Sedano B; ; Kulisevsky J; Martínez-Martín P; Santos-García D; Mir P
Parkinsonism Relat Disord; 2021 Jul; 88():68-75. PubMed ID: 34144230
[TBL] [Abstract][Full Text] [Related]
6. Lower volume, more impairment: reduced cholinergic basal forebrain grey matter density is associated with impaired cognition in Parkinson disease.
Barrett MJ; Sperling SA; Blair JC; Freeman CS; Flanigan JL; Smolkin ME; Manning CA; Druzgal TJ
J Neurol Neurosurg Psychiatry; 2019 Nov; 90(11):1251-1256. PubMed ID: 31175168
[TBL] [Abstract][Full Text] [Related]
7. Olfaction, cholinergic basal forebrain degeneration, and cognition in early Parkinson disease.
Barrett MJ; Murphy JM; Zhang J; Blair JC; Flanigan JL; Nawaz H; Dalrymple WA; Sperling SA; Patrie J; Druzgal TJ
Parkinsonism Relat Disord; 2021 Sep; 90():27-32. PubMed ID: 34348192
[TBL] [Abstract][Full Text] [Related]
8. Basal Forebrain Atrophy, Cortical Thinning, and Amyloid-β Status in Parkinson's disease-Related Cognitive Decline.
Labrador-Espinosa MA; Silva-Rodríguez J; Reina-Castillo MI; Mir P; Grothe MJ
Mov Disord; 2023 Oct; 38(10):1871-1880. PubMed ID: 37492892
[TBL] [Abstract][Full Text] [Related]
9. Baseline and longitudinal grey matter changes in newly diagnosed Parkinson's disease: ICICLE-PD study.
Mak E; Su L; Williams GB; Firbank MJ; Lawson RA; Yarnall AJ; Duncan GW; Owen AM; Khoo TK; Brooks DJ; Rowe JB; Barker RA; Burn DJ; O'Brien JT
Brain; 2015 Oct; 138(Pt 10):2974-86. PubMed ID: 26173861
[TBL] [Abstract][Full Text] [Related]
10. Progression of subcortical atrophy in mild Parkinson's disease and its impact on cognition.
Foo H; Mak E; Yong TT; Wen MC; Chander RJ; Au WL; Sitoh YY; Tan LC; Kandiah N
Eur J Neurol; 2017 Feb; 24(2):341-348. PubMed ID: 27943468
[TBL] [Abstract][Full Text] [Related]
11. The burden of white matter hyperintensities is a predictor of progressive mild cognitive impairment in patients with Parkinson's disease.
Sunwoo MK; Jeon S; Ham JH; Hong JY; Lee JE; Lee JM; Sohn YH; Lee PH
Eur J Neurol; 2014 Jun; 21(6):922-e50. PubMed ID: 24661277
[TBL] [Abstract][Full Text] [Related]
12. Cholinergic basal forebrain and hippocampal structure influence visuospatial memory in Parkinson's disease.
Berlot R; Pirtošek Z; Brezovar S; Koritnik B; Teipel SJ; Grothe MJ; Ray NJ
Brain Imaging Behav; 2022 Feb; 16(1):118-129. PubMed ID: 34176042
[TBL] [Abstract][Full Text] [Related]
13. Exploratory analysis of neuropsychological and neuroanatomical correlates of progressive mild cognitive impairment in Parkinson's disease.
Lee JE; Cho KH; Song SK; Kim HJ; Lee HS; Sohn YH; Lee PH
J Neurol Neurosurg Psychiatry; 2014 Jan; 85(1):7-16. PubMed ID: 23828835
[TBL] [Abstract][Full Text] [Related]
14. Hippocampal subfield atrophy of CA1 and subicular structures predict progression to dementia in idiopathic Parkinson's disease.
Low A; Foo H; Yong TT; Tan LCS; Kandiah N
J Neurol Neurosurg Psychiatry; 2019 Jun; 90(6):681-687. PubMed ID: 30683708
[TBL] [Abstract][Full Text] [Related]
15. Multimodal magnetic resonance imaging investigation of basal forebrain damage and cognitive deficits in Parkinson's disease.
Gargouri F; Gallea C; Mongin M; Pyatigorskaya N; Valabregue R; Ewenczyk C; Sarazin M; Yahia-Cherif L; Vidailhet M; Lehéricy S
Mov Disord; 2019 Apr; 34(4):516-525. PubMed ID: 30536444
[TBL] [Abstract][Full Text] [Related]
16. Structural and molecular cholinergic imaging markers of cognitive decline in Parkinson's disease.
Schumacher J; Kanel P; Dyrba M; Storch A; Bohnen NI; Teipel S; Grothe MJ
Brain; 2023 Dec; 146(12):4964-4973. PubMed ID: 37403733
[TBL] [Abstract][Full Text] [Related]
17. Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease.
Weintraub D; Dietz N; Duda JE; Wolk DA; Doshi J; Xie SX; Davatzikos C; Clark CM; Siderowf A
Brain; 2012 Jan; 135(Pt 1):170-80. PubMed ID: 22108576
[TBL] [Abstract][Full Text] [Related]
18. Clinical and Cerebral Metabolic Changes in Parkinson's Disease With Basal Forebrain Atrophy.
Gang M; Baba T; Hosokai Y; Nishio Y; Kikuchi A; Hirayama K; Hasegawa T; Aoki M; Takeda A; Mori E; Suzuki K
Mov Disord; 2020 May; 35(5):825-832. PubMed ID: 31971293
[TBL] [Abstract][Full Text] [Related]
19. Tracking Cortical Changes Throughout Cognitive Decline in Parkinson's Disease.
Filippi M; Canu E; Donzuso G; Stojkovic T; Basaia S; Stankovic I; Tomic A; Markovic V; Petrovic I; Stefanova E; Kostic VS; Agosta F
Mov Disord; 2020 Nov; 35(11):1987-1998. PubMed ID: 32886420
[TBL] [Abstract][Full Text] [Related]
20. Frontal atrophy as a marker for dementia conversion in Parkinson's disease with mild cognitive impairment.
Chung SJ; Yoo HS; Lee YH; Lee HS; Ye BS; Sohn YH; Kwon H; Lee PH
Hum Brain Mapp; 2019 Sep; 40(13):3784-3794. PubMed ID: 31090134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
